Cargando…
Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China
PURPOSE: To characterize the incidence, risk factors and survival of patients with brain metastases at initial diagnosis of metastatic breast cancer (MBC) in China. METHODS: The China National Cancer Center database was used to identify 2087 MBC patients diagnosed between 2003 and 2015. Clinicopatho...
Autores principales: | Li, Yiqun, Li, Qiao, Mo, Hongnan, Guan, Xiuwen, Lin, Shaoyan, Wang, Zijing, Chen, Yimeng, Zhang, Ye, Zhang, Dainan, Chen, Shanshan, Cai, Ruigang, Wang, Jiayu, Luo, Yang, Fan, Ying, Yuan, Peng, Zhang, Pin, Li, Qing, Ma, Fei, Xu, Binghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736978/ https://www.ncbi.nlm.nih.gov/pubmed/33310633 http://dx.doi.org/10.1016/j.breast.2020.11.021 |
Ejemplares similares
-
Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population
por: Lin, Shaoyan, et al.
Publicado: (2021) -
Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population
por: Lin, Shaoyan, et al.
Publicado: (2021) -
Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, China
por: Li, Yiqun, et al.
Publicado: (2021) -
Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China
por: Lin, Shaoyan, et al.
Publicado: (2020) -
In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China
por: Li, Yiqun, et al.
Publicado: (2022)